US FDA eases Teva headache with Ajovy approval
Regulatory setbacks at Teva’s CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.
Archives for September 18, 2018
Oncology vaccine ensured 100% survival rate in lab studies
Scientists demonstrated that an adjuvant to an immunotherapy vaccine resulted in a 100% survival rate in mice with aggressive melanoma.
Boehringer buys ViraTherapeutics to help make ‘cold’ tumours ‘hot’
Boehringer Ingelheim will pay €210m for ViraTherapeutics to boost viral-based immune-oncology R&D.